Company history

Feb. 2010 BONAC Corporation founded in Kurume, Fukuoka prefecture
Jul. 2011 Platform technology patents application submitted for nucleic acid medicine
Apr. 2012 Domestic platform technology patents obtained for nucleic acid medicine (nkRNA®, PnkRNA®)
Jul. 2012 Tokyo Branch opened in Chuo-ku, Tokyo, to strengthen the sales division following up on acquisitiontof patents
Dec. 2012 Endowed chair for advanced medicine at Tokyo Medical University established in Shinjuku-ku, Tokyo
Feb. 2013 Bioresearch center in Okinawa opened in Uruma, Okinawa prefecture
Apr. 2013 Endowed chair in the Department of Molecular Immunology at the Institute of Industrial Science, the University of Tokyo established in Meguro-ku, Tokyo
Jun. 2013 Tokyo Branch relocated in Chiyoda-ku, Tokyo
Dec. 2013 Third-party allocation of new shares (capital: 174 million yen)
Dec. 2015 Third-party allocation of new shares (capital: 944 million yen)
Jan. 2016 Third-party allocation of new shares (capital: 1,424million yen)
May. 2016 Tokyo Branch relocated in Uchikanda,Chiyoda-ku,Tokyo
Jun. 2016 Third‐party allocation of new shares(Capital:1,477million yen)
Jul. 2017
Sep. 2017
Third – Party allocation of new shares(Capital:3,877million yen)

ページ上部へ